 .15), but it was associated with a signiﬁcantly higher
risk of hemorrhagic stroke (RR, 1.67; 95% CI, 1.10-2.56; P ¼
.02) and major bleeding events (RR, 1.90; 95% CI, 1.46-2.48;
P < .01). Long-term combination therapy also failed to
